Beau Ances on amyloid biomarkers in Alzheimer’s
The Lancet Neurology in conversation with - A podcast by The Lancet Group - Thursdays
Categories:
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.Read the full article:Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's diseaseContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook....
